Literature DB >> 25935112

Structural determinants of Smad function in TGF-β signaling.

Maria J Macias1, Pau Martin-Malpartida2, Joan Massagué3.   

Abstract

Smad transcription factors are central to the signal transduction pathway that mediates the numerous effects of the transforming growth factor β (TGF-β) superfamily of cytokines in metazoan embryo development as well as in adult tissue regeneration and homeostasis. Although Smad proteins are conserved, recent genome-sequencing projects have revealed their sequence variation in metazoan evolution, human polymorphisms, and cancer. Structural studies of Smads bound to partner proteins and target DNA provide a framework for understanding the significance of these evolutionary and pathologic sequence variations. We synthesize the extant mutational and structural data to suggest how genetic variation in Smads may affect the structure, regulation, and function of these proteins. We also present a web application that compares Smad sequences and displays Smad protein structures and their disease-associated variants.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Smad DNA binding; Smad conservation/variation; Smad proteins; Smad structure; Smad-binding proteins; TGF-β signaling; cancer mutations

Mesh:

Substances:

Year:  2015        PMID: 25935112      PMCID: PMC4485443          DOI: 10.1016/j.tibs.2015.03.012

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  72 in total

1.  Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal.

Authors:  Luis C Fuentealba; Edward Eivers; Atsushi Ikeda; Cecilia Hurtado; Hiroki Kuroda; Edgar M Pera; Edward M De Robertis
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 2.  Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Authors:  Yasumichi Inoue; Takeshi Imamura
Journal:  Cancer Sci       Date:  2008-09-18       Impact factor: 6.716

3.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.

Authors:  A Hata; R S Lo; D Wotton; G Lagna; J Massagué
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

4.  MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.

Authors:  K Eppert; S W Scherer; H Ozcelik; R Pirone; P Hoodless; H Kim; L C Tsui; B Bapat; S Gallinger; I L Andrulis; G H Thomsen; J L Wrana; L Attisano
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

5.  Endofin acts as a Smad anchor for receptor activation in BMP signaling.

Authors:  Weibin Shi; Chenbei Chang; Shuyi Nie; Shutao Xie; Mei Wan; Xu Cao
Journal:  J Cell Sci       Date:  2007-03-13       Impact factor: 5.285

6.  Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.

Authors:  Gopal Sapkota; Marie Knockaert; Claudio Alarcón; Ermelinda Montalvo; Ali H Brivanlou; Joan Massagué
Journal:  J Biol Chem       Date:  2006-11-02       Impact factor: 5.157

Review 7.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 8.  Tgf-beta superfamily signaling in embryonic development and homeostasis.

Authors:  Mary Y Wu; Caroline S Hill
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

9.  The Trichoplax genome and the nature of placozoans.

Authors:  Mansi Srivastava; Emina Begovic; Jarrod Chapman; Nicholas H Putnam; Uffe Hellsten; Takeshi Kawashima; Alan Kuo; Therese Mitros; Asaf Salamov; Meredith L Carpenter; Ana Y Signorovitch; Maria A Moreno; Kai Kamm; Jane Grimwood; Jeremy Schmutz; Harris Shapiro; Igor V Grigoriev; Leo W Buss; Bernd Schierwater; Stephen L Dellaporta; Daniel S Rokhsar
Journal:  Nature       Date:  2008-08-21       Impact factor: 49.962

10.  Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom.

Authors:  Lukasz Huminiecki; Leon Goldovsky; Shiri Freilich; Aristidis Moustakas; Christos Ouzounis; Carl-Henrik Heldin
Journal:  BMC Evol Biol       Date:  2009-02-03       Impact factor: 3.260

View more
  129 in total

1.  An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells.

Authors:  H-R Zhang; X-D Wang; X Yang; D Chen; J Hao; R Cao; X-Z Wu
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 2.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

4.  TGIF1 homeodomain interacts with Smad MH1 domain and represses TGF-β signaling.

Authors:  Ewelina Guca; David Suñol; Lidia Ruiz; Agnieszka Konkol; Jorge Cordero; Carles Torner; Eric Aragon; Pau Martin-Malpartida; Antoni Riera; Maria J Macias
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

5.  A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.

Authors:  Anil Korkut; Sobia Zaidi; Rupa S Kanchi; Shuyun Rao; Nancy R Gough; Andre Schultz; Xubin Li; Philip L Lorenzi; Ashton C Berger; Gordon Robertson; Lawrence N Kwong; Mike Datto; Jason Roszik; Shiyun Ling; Visweswaran Ravikumar; Ganiraju Manyam; Arvind Rao; Simon Shelley; Yuexin Liu; Zhenlin Ju; Donna Hansel; Guillermo de Velasco; Arjun Pennathur; Jesper B Andersen; Colm J O'Rourke; Kazufumi Ohshiro; Wilma Jogunoori; Bao-Ngoc Nguyen; Shulin Li; Hatice U Osmanbeyoglu; Jaffer A Ajani; Sendurai A Mani; Andres Houseman; Maciej Wiznerowicz; Jian Chen; Shoujun Gu; Wencai Ma; Jiexin Zhang; Pan Tong; Andrew D Cherniack; Chuxia Deng; Linda Resar; John N Weinstein; Lopa Mishra; Rehan Akbani
Journal:  Cell Syst       Date:  2018-09-26       Impact factor: 10.304

Review 6.  Transcriptional Control by the SMADs.

Authors:  Caroline S Hill
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

7.  Absolute Ligand Discrimination by Dimeric Signaling Receptors.

Authors:  Sepehr Fathi; Chitra R Nayak; Jordan J Feld; Anton G Zilman
Journal:  Biophys J       Date:  2016-09-06       Impact factor: 4.033

8.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

Review 9.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

10.  Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.

Authors:  A R Garcia-Rendueles; J S Rodrigues; M E R Garcia-Rendueles; M Suarez-Fariña; S Perez-Romero; F Barreiro; I Bernabeu; J Rodriguez-Garcia; L Fugazzola; T Sakai; F Liu; J Cameselle-Teijeiro; S B Bravo; C V Alvarez
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.